Proposed guidelines for use of dermal and subdermal fillers

Giornale Italiano di Dermatologia e Venereologia

Volumn 143, Issue 3, 2008, Pages 187-193

  Cirillo, P ^a   Benci, M ^a   Bartoletti, E ^a   Bertana, C ^a  

^a NONE   (Italy)

Author keywords

Guidelines; Skin aging; Skin care; Surgery, plastic

Indexed keywords

ABSCESS; ADVERSE OUTCOME; CLINICAL PRACTICE; DERMATOLOGICAL PROCEDURES; DEVICE; DIAGNOSTIC PROCEDURE; ESTHETICS; GRANULOMA; HEALTH CARE PERSONNEL; HEMATOMA; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATION; INFORMED CONSENT; MEDICAL RECORD; MEDICAL SOCIETY; MEDICOLEGAL ASPECT; NONHUMAN; PAIN; PARENTAL CONSENT; PATIENT SAFETY; PLASTIC SURGERY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SKIN CARE; SKIN NECROSIS; SKIN NODULE; STRUCTURED QUESTIONNAIRE;

EID: 46749086211     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Griffiths CEM. The British Association of Dermatologists guidelines for the management of skin disease. Br J Dermatol 1999;141:396-97.
2. Cirillo P, Benci M, Silvestris P, Pepe NR, Amaturo A. Atti del Congresso 16-18 settembre 2004-Pisa-Congresso Nazionale SICPRE: Relazione-denuncia sulla carenza legislativa in materia di dispositivi medico chirurgici, in relazione soprattutto ai filler permanenti, e raccolta di complicanze.
3. Cirillo PF, Silverstris P, Benci M. Filler riassorbibili o non riassorbibili? Dermatologia Ambulatoriale 2005:1/2:14-17.
4. Benci M, Cirillo P, Bertana C, Fabianelli F. Complicanze da iniezione di filler riassorbibili e non riassorbibili e loro gestione. EMC (Elsevier SAS, Paris). Cosmetologia Medica e Medicina degli Inestetismi Cutanei 2006;50-330-A-30.
5. Benci M. Filler, normative comunitarie per il loro utilizzo. Kosmè 2002;2:49-50.
6. [No authors listed]. Guidelines of care for office surgical facilities. Part I. J Am Acad Dermatol 1992;26:763-5.
7. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW et al. Guidelines of care for chemical peeling. J Am Acad Dermatol 1995;33:497-503.
8. Drake LA, Ceilley RI, Cornelison RL, Dinehart SM, Dorner W, Goltz RW et al. Guidelines of care for office surgical facilities. Part II. Self-Assessment checklist. J Am Acad Dermatol 1995;33:265-70.
9. [No authors listed] Guidelines of care for tissue augmentation : collagen implant. J Am Acad Dermatol 1996;34:698-702.
10. Seth L, Matarasso MD, Carruthers JD, Mark L, Jewell MD and the Restylane Consensus Group. Consensus Recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (resty-lane). Plastic and reconstructive surgery 2006;117:3s.
11. Rohrich RJ. Semipermanent and permanent dermal/subdermal fillers supplement. Plast Reconstr Surg 2006;118(3 Suppl):1S-3S.
12. Bertana C. Acido polilattico: linee-guida. Dermatologia Ambulatoriale Anno XIII;2005:1-2.
13. Labrini G, Guerriero G, Landi FL, Teofoli P, Cirfera V. Peeling chimici. Linee guida. Dermatologia Ambulatoriale Anno XIV;2006:2.
14. Grippando FR, Sparvieri C, Rossi A, Onesti MG, Scuderi N. Ultrasound assisted liposuction for the removal of siliconomas. Scand J Plast Reconstr Surg Hand Surg 2004;38:21-6.
15. Onesti MG, Renzi LF, Paoletti F, Scuderi N. Use of polilactic acid in face lipodystrofy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART). Acta Chir Plast 2004;46:12-5.
16. Onesti MG, Mazzocchi M, Paoletti F, Tanzilli P. La correzione dei dimorfismi nei pazienti con infezione da HIV in trattamento con terapia antiretrovirale. Giornale Italiano di Malattie Infettive 2005;(Suppl 2)11:28-31.
17. Onesti MG, Buccheri E, Mariano A, Papasso A, Madonna Terracina FS, Mazzocchi M et al. Silicone liquido iniettabile: revisione della letteratura e nostra esperienza. Dermatologia Clinica 2006;4:211-5.
18. Dessy LA, Mazzocchi M, Monarca C, Onesti MG, Scuderi N. Combined transdermal scopolamine and botulin toxin A to treat a parotid fistul after face-lift in a patient with siliconomas. Int J Oral Maxillofac Surg. 2007;36:949-52.
19. Benci M, Lorusso B, Salti G, Cirillo P, Lotti T. About the safety an efficacy of the available fillers: four granulomatous reactions due to permanent filling substances in the perioral region. J Eur Acad Dermatol Venereol 164:16(Suppl 1);2002.